Medically reviewed against peer-reviewed clinical research | Updated: May 2026 Key TakeawaysYes, semaglutide is linked to lean mass loss that
Last updated: May 2026 | Reviewed against clinical trial data from STEP 1 to STEP 5 Key TakeawaysMost
A clinically-grounded guide to understanding pancreatitis risk on semaglutide, what the latest 2025 and 2026 data actually show, and how
Medically reviewed health explainer · Last updated: May 2026 Key Takeaways • Semaglutide carries a boxed warning for medullary thyroid
Key Takeaways Gastrointestinal symptoms, mainly nausea, vomiting, and diarrhea, are the most common side effects and typically improve within 4
KEYTAKEAWAYS 5 to 11% of people on semaglutide report fatigue, with the highest rates seen in Wegovy usersThe first 4
Key Takeaways In the STEP clinical trials, approximately 3% of semaglutide users reported hair loss versus 1% on placebo. The
KEY TAKEAWAYSSemaglutide slows gastric emptying and whole-gut motility, causing constipation in up to 24% of people on higher doses.Symptoms are
One Drug. Three Products. Everything You Need to Know. Key Takeaways Semaglutide is a single molecule sold under three brand
Key Takeaways • Nausea, diarrhea, and vomiting are the most common Wegovy side effects, affecting up to 44% of users
